立方制药
(003020)
| 流通市值：25.65亿 | | | 总市值：34.73亿 |
| 流通股本：1.69亿 | | | 总股本：2.28亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 375,769,426.76 | 226,877,499.7 | 285,062,123.74 | 413,893,621.67 |
| 交易性金融资产 | 230,336,118.74 | 325,584,102.48 | 200,526,320.56 | 40,270,405.02 |
| 应收票据及应收账款 | 343,337,819.07 | 357,400,696.43 | 434,758,849.23 | 452,439,172.94 |
| 其中：应收票据 | - | - | - | 0 |
| 应收账款 | 343,337,819.07 | 357,400,696.43 | 434,758,849.23 | 452,439,172.94 |
| 应收款项融资 | 29,453,753.55 | 39,570,646.22 | 53,242,281.56 | 35,059,892.79 |
| 预付款项 | 22,706,778.8 | 16,039,757.6 | 18,570,941.37 | 15,118,020.22 |
| 其他应收款合计 | 5,005,241.17 | 5,784,482.62 | 4,790,673.9 | 4,622,142.25 |
| 存货 | 245,108,908.07 | 249,186,960.18 | 227,631,684.81 | 204,499,266.78 |
| 其他流动资产 | 15,314,970.51 | 16,123,385.41 | 12,050,085.19 | 10,336,296.88 |
| 流动资产合计 | 1,267,033,016.67 | 1,236,567,530.64 | 1,236,632,960.36 | 1,176,238,818.55 |
| 非流动资产: | | | | |
| 长期股权投资 | 156,448,069.31 | 148,928,784.79 | 185,494,586.25 | 177,331,576.31 |
| 其他权益工具投资 | 16,439,136.58 | 16,439,136.58 | 16,439,136.58 | 16,439,136.58 |
| 其他非流动金融资产 | - | 3,000,000 | 3,000,000 | 3,000,000 |
| 投资性房地产 | 26,956,222.43 | 27,357,645.05 | 27,756,056.17 | 28,157,954.29 |
| 固定资产 | 897,142,081.68 | 913,357,206.1 | 919,462,658.28 | 928,036,154.63 |
| 在建工程 | 60,504,789.54 | 57,314,716.64 | 53,459,580.97 | 51,663,542.31 |
| 生产性生物资产 | 668,991.19 | 684,205.25 | 690,079.31 | 687,601.22 |
| 使用权资产 | 6,223,911.2 | 4,636,142.35 | 5,359,536.51 | 5,270,889.94 |
| 无形资产 | 91,856,345.71 | 94,100,120.04 | 95,399,783.93 | 97,614,829.24 |
| 开发支出 | 2,284,400 | 1,866,800 | 2,432,000 | 2,447,600 |
| 商誉 | 74,440,520.92 | 74,440,520.92 | 74,440,520.92 | 74,440,520.92 |
| 长期待摊费用 | 4,209,363.03 | 4,153,806.35 | 4,060,442.31 | 1,414,205.7 |
| 递延所得税资产 | 18,593,282.21 | 17,320,562.12 | 16,112,115.57 | 15,809,006.5 |
| 其他非流动资产 | 20,248,796.19 | 14,415,273.34 | 9,586,082.25 | 7,274,104.22 |
| 非流动资产合计 | 1,376,015,909.99 | 1,378,014,919.53 | 1,413,692,579.05 | 1,409,587,121.86 |
| 资产总计 | 2,643,048,926.66 | 2,614,582,450.17 | 2,650,325,539.41 | 2,585,825,940.41 |
| 流动负债: | | | | |
| 短期借款 | 19,181,591.43 | 10,000,000 | - | - |
| 应付票据及应付账款 | 309,140,673.52 | 340,714,790.83 | 366,403,527.5 | 349,460,610.26 |
| 其中：应付票据 | 0 | - | - | - |
| 应付账款 | 309,140,673.52 | 340,714,790.83 | 366,403,527.5 | 349,460,610.26 |
| 预收款项 | 40,368.25 | 336,165.32 | - | 407,867.36 |
| 合同负债 | 13,768,713.69 | 9,328,249.18 | 27,491,120.34 | 7,585,152.51 |
| 应付职工薪酬 | 29,206,767.87 | 23,133,485.55 | 19,944,887.3 | 34,517,301.46 |
| 应交税费 | 20,727,421.78 | 27,390,657.26 | 29,100,717.83 | 28,666,764.44 |
| 其他应付款合计 | 91,079,990.8 | 92,264,001.47 | 95,390,885.09 | 96,421,756.48 |
| 一年内到期的非流动负债 | 2,538,116.84 | 2,349,983.39 | 2,538,116.84 | 2,538,116.84 |
| 其他流动负债 | 1,359,191.26 | 985,761.75 | 1,318,948.47 | 983,254.09 |
| 流动负债合计 | 487,042,835.44 | 506,503,094.75 | 542,188,203.37 | 520,580,823.44 |
| 非流动负债: | | | | |
| 长期借款 | 108,072,900 | 78,102,717.5 | 69,652,200 | 59,644,700 |
| 租赁负债 | 1,796,207.6 | 1,428,092.2 | 1,007,710.05 | 1,714,414.38 |
| 递延收益 | 41,961,036.93 | 42,267,112.04 | 43,406,139.49 | 44,895,813.26 |
| 递延所得税负债 | 6,275,326.83 | 6,618,282.86 | 7,014,536.39 | 7,358,097.69 |
| 非流动负债合计 | 158,105,471.36 | 128,416,204.6 | 121,080,585.93 | 113,613,025.33 |
| 负债合计 | 645,148,306.8 | 634,919,299.35 | 663,268,789.3 | 634,193,848.77 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 228,218,618 | 228,218,618 | 190,182,182 | 190,182,182 |
| 资本公积 | 472,009,459.76 | 472,009,459.76 | 510,045,895.76 | 510,045,895.76 |
| 盈余公积 | 97,154,751.67 | 97,154,751.67 | 97,154,751.67 | 97,154,751.67 |
| 未分配利润 | 1,063,531,208.61 | 1,042,711,629.45 | 1,047,018,455.94 | 1,011,561,158.96 |
| 归属于母公司股东权益合计 | 1,860,914,038.04 | 1,840,094,458.88 | 1,844,401,285.37 | 1,808,943,988.39 |
| 少数股东权益 | 136,986,581.82 | 139,568,691.94 | 142,655,464.74 | 142,688,103.25 |
| 股东权益合计 | 1,997,900,619.86 | 1,979,663,150.82 | 1,987,056,750.11 | 1,951,632,091.64 |
| 负债和股东权益合计 | 2,643,048,926.66 | 2,614,582,450.17 | 2,650,325,539.41 | 2,585,825,940.41 |
| 公告日期 | 2026-10-30 | 2026-08-29 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |